High‐dose oral baclofen

Charles R. Smith, Nicholas G. LaRocca, Barbara S. Giesser, Labe C. Scheinberg

Neurology · 1991 · 70 citations · 0 references

Concepts

Abstract

We reviewed a 10% random sample of charts from an outpatient clinic for multiple sclerosis to determine the frequency with which baclofen was prescribed for spasticity in high doses (greater than 80 mg/d). About 20% of patients had taken high-dose baclofen, and 15% were still receiving a high dose. Taking a high dose was not associated with discontinuing treatment.